Oseltamivir
Oseltamivir is a neuraminidase antiviral agent used to treat and
prophylaxis influenza virus A (including pandemic H1N1) and B infection.
Oseltamivir exercises its antiviral function by inhibiting the function
of the viral neuraminidase enzyme located on the virus surface, which
inhibits host cell budding, viral replication, and infectivity [37].
According to the CDC, data from clinical trials and observational
studies have shown that early antiviral therapy can shorten the length
of symptoms of fever and illness, and reduce the risk of other health
complications (including pneumonia and respiratory failure).Oseltamivir
is being screened against 2019-nCoV and is undergoing clinical trial
[40].